AnaptysBio (ANAB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

Guggenheim analyst Yatin Suneja notes Johnson & Johnson (JNJ) released two abstract titles for the upcoming European Congress of ...

In a report released on March 24, David Risinger from Leerink Partners maintained a Buy rating on AnaptysBio (ANAB – Research Report). The ...

AnaptysBio, Inc. (ANAB) shares rallied 9.5% in the last trading session to close at $18.71. This move can be attributable to notable volume with a higher number of shares being traded than in a ...

Intuitive Machines reported fourth-quarter revenue of $54.66 million, missing analyst estimates of $55.77 million, according ...

AnaptysBio shares rose 7.2% on a share-repurchase program authorized to buy back up to $75 million of the company's common stock. Shares were recently trading around $18.31. The stock is down 15% over ...

Shares of AnaptysBio (NASDAQ: ANAB) climbed 12% today as the company announced a significant stock repurchase plan, signaling confidence in its financial position and future prospects. The ...

AnaptysBio (NASDAQ:ANAB – Get Free Report) and Silo Pharma (NASDAQ:SILO – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses ...

SAN DIEGO - AnaptysBio, Inc. (NASDAQ:ANAB), a clinical-stage biotechnology company currently valued at $524 million, has announced the authorization of a stock repurchase plan. Under this plan ...

ANAB opened at $18.44 on Wednesday. AnaptysBio has a 12 month low of $12.21 and a 12 month high of $41.31. The business’s 50-day moving average price is $16.95 and its 200-day moving average ...